• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall ELAntiSARSCoV2 IgG Kit

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall ELAntiSARSCoV2 IgG Kit see related information
Date Initiated by Firm October 05, 2020
Create Date August 27, 2021
Recall Status1 Terminated 3 on February 15, 2022
Recall Number Z-2382-2021
Recall Event ID 88478
Product Classification Reagent, coronavirus serological - Product Code QKO
Product EL-Anti-SARS-CoV-2 IgG Kit, Catalog #104-130. Submitted as EUA202128
Code Information Lot numbers 05204351, exp. 5/1/2021, and 05204368, exp. 05/19/2021.
Recalling Firm/
Manufacturer
Thera Test Laboratories, Inc.
1120 N Du Page Ave
Lombard IL 60148-1247
For Additional Information Contact Mr. Anthony Tate
630-627-6069 Ext. 241
Manufacturer Reason
for Recall
The cross-reactivity of the device may present an increased level of potential false positives. Submitted as EUA202128
FDA Determined
Cause 2
No Marketing Application
Action The firm initiated the recall using undated letters attached to emails sent on 10/7/2020 requesting return of product.
Quantity in Commerce 19 kits
Distribution US Nationwide distribution in the states of California, Florida, Illinois, Indiana, North Carolina, and Texas.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-